|
Name |
(E)-2,6-Dimethylocta-5,7-dien-4-one
|
Molecular Formula | C10H16O | |
IUPAC Name* |
(5E)-2,6-dimethylocta-5,7-dien-4-one
|
|
SMILES |
CC(C)CC(=O)/C=C(\C)/C=C
|
|
InChI |
InChI=1S/C10H16O/c1-5-9(4)7-10(11)6-8(2)3/h5,7-8H,1,6H2,2-4H3/b9-7+
|
|
InChIKey |
RJXKHBTYHGBOKV-VQHVLOKHSA-N
|
|
Synonyms |
(E)-Tagetone; trans-Tagetone; (E)-2,6-Dimethylocta-5,7-dien-4-one; 6752-80-3; Tagetone, (E)-; (5E)-2,6-dimethylocta-5,7-dien-4-one; 9V8N4C9UN5; 5,7-Octadien-4-one, 2,6-dimethyl-, (E)-; UNII-9V8N4C9UN5; 2,6-Dimethyl-5,7-octadien-4-one; EINECS 229-813-0; TAGETONE, TRANS-; SCHEMBL11018652; DTXSID501317899; (5E)-2,6-Dimethyl-5,7-octadien-4-one; (5E)-2,6-dimethyl-octa-5,7-dien-4-one; 5,7-Octadien-4-one, 2,6-dimethyl-, (5E)-; Q27273267
|
|
CAS | 6752-80-3 | |
PubChem CID | 5368938 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 152.23 | ALogp: | 3.1 |
HBD: | 0 | HBA: | 1 |
Rotatable Bonds: | 4 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 17.1 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.445 |
Caco-2 Permeability: | -4.338 | MDCK Permeability: | 0.00003070 |
Pgp-inhibitor: | 0.002 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.002 |
30% Bioavailability (F30%): | 0.002 |
Blood-Brain-Barrier Penetration (BBB): | 0.905 | Plasma Protein Binding (PPB): | 77.34% |
Volume Distribution (VD): | 1.467 | Fu: | 19.34% |
CYP1A2-inhibitor: | 0.389 | CYP1A2-substrate: | 0.577 |
CYP2C19-inhibitor: | 0.349 | CYP2C19-substrate: | 0.905 |
CYP2C9-inhibitor: | 0.239 | CYP2C9-substrate: | 0.904 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.648 |
CYP3A4-inhibitor: | 0.034 | CYP3A4-substrate: | 0.329 |
Clearance (CL): | 9.93 | Half-life (T1/2): | 0.84 |
hERG Blockers: | 0.013 | Human Hepatotoxicity (H-HT): | 0.399 |
Drug-inuced Liver Injury (DILI): | 0.185 | AMES Toxicity: | 0.12 |
Rat Oral Acute Toxicity: | 0.537 | Maximum Recommended Daily Dose: | 0.358 |
Skin Sensitization: | 0.93 | Carcinogencity: | 0.829 |
Eye Corrosion: | 0.972 | Eye Irritation: | 0.988 |
Respiratory Toxicity: | 0.94 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001735 | 1.000 | D0ZK8H | 0.263 | ||||
ENC000237 | 0.452 | D0H6VY | 0.255 | ||||
ENC000376 | 0.364 | D00WUF | 0.244 | ||||
ENC000351 | 0.364 | D04MWJ | 0.222 | ||||
ENC001568 | 0.350 | D0M1PQ | 0.200 | ||||
ENC000685 | 0.342 | D07ZTO | 0.196 | ||||
ENC000241 | 0.342 | D0G8SQ | 0.196 | ||||
ENC000246 | 0.333 | D0R1QE | 0.193 | ||||
ENC001203 | 0.316 | D05BQK | 0.186 | ||||
ENC000603 | 0.308 | D0R3QY | 0.186 |